Cargando…
Tropomyosin autoantibodies associated with checkpoint inhibitor myositis
This brief report details the measurement and identification of IgA antibodies to tropomyosin in a case of presumed ocular myositis with paraspinal myositis in a patient with metastatic uveal melanoma treated with checkpoint inhibitors. High-throughput functional protein microarray analysis and path...
Autores principales: | Zaenker, Pauline, Prentice, David, Ziman, Melanie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458639/ https://www.ncbi.nlm.nih.gov/pubmed/32923166 http://dx.doi.org/10.1080/2162402X.2020.1804703 |
Ejemplares similares
-
Checkpoint inhibitor immune-related adverse events: A focused review on autoantibodies and B cells as biomarkers, advancements and future possibilities
por: Taylor, John, et al.
Publicado: (2023) -
Anti-mitochondrial autoantibodies are associated with cardiomyopathy, dysphagia, and features of more severe disease in adult-onset myositis
por: Sabbagh, Sara E., et al.
Publicado: (2021) -
Checkpoint inhibitor induced myositis – The value of MRI STIR
por: Erritzøe-Jervild, Mai, et al.
Publicado: (2023) -
Association between self-reported race and ethnicity and myositis-specific autoantibodies in a diverse cohort of patients with inflammatory myopathy
por: Beam, Michael J., et al.
Publicado: (2023) -
Clinical Significance of Myositis-Specific and Myositis-Associated Antibody Profiles in Dermatomyositis
por: Babu, Anuradha K., et al.
Publicado: (2022)